Consensus Addus HomeCare Corporation

Equities

ADUS

US0067391062

Market Closed - Nasdaq 01:30:00 22/06/2024 am IST 5-day change 1st Jan Change
118.4 USD +1.33% Intraday chart for Addus HomeCare Corporation +1.73% +27.57%

Evolution of the average Target Price on Addus HomeCare Corporation

Price target over the last 5 years

History of analyst recommendation changes

d.AFLBKMn4ZI5wqmP0QH-yZL7n8xQ5y__XDIGMW4DBcCo.bRWPX4C5UNkxnyS8OE_3Jf2lwCdMs5WaZvvtLciLHEdwJPB8-8xJ4EnkVw~fca674b1fd3e5a46ebcd868f492fcac3
TD Cowen Adjusts Addus HomeCare Price Target to $128 From $119, Maintains Buy Rating MT
Oppenheimer Adjusts Addus HomeCare Price Target to $130 From $118, Maintains Outperform Rating MT
Stephens Adjusts Addus HomeCare Price Target to $128 From $120, Maintains Overweight Rating MT
RBC Raises Price Target on Addus HomeCare to $129 From $102, Keeps Outperform Rating Amid 'Solid' Q1 Results MT
RBC Raises Price Target on Addus HomeCare to $129 From $102, Keeps Outperform Rating MT
BofA Securities Adjusts Addus HomeCare Price Target to $118 From $115, Maintains Buy Rating MT
Barclays Downgrades Addus HomeCare to Underweight From Equalweight, Cuts Price Target to $83 From $88 MT
Barclays Initiates Addus HomeCare With Equalweight Rating, Price Target is $88 MT
TD Cowen Initiates Addus HomeCare at Outperform Rating With $105 Price Target MT
Stephens Adjusts Price Target on Addus HomeCare to $105 From $110, Maintains Overweight Rating MT
RBC Cuts Price Target on Addus HomeCare to $102 From $109, Cites Industry Multiple Contraction, Keeps Outperform Rating MT
Stephens Adjusts Price Target on Addus HomeCare to $110 From $100, Maintains Overweight Rating MT
Raymond James Adjusts Price Target on Addus HomeCare to $105 From $100, Maintains Outperform Rating MT
Raymond James Adjusts Price Target on Addus HomeCare to $100 From $125, Maintains Outperform Rating MT
Oppenheimer Adjusts Addus HomeCare Price Target to $118 From $130, Maintains Outperform Rating MT
RBC Capital Adjusts Price Target on Addus HomeCare to $109 From $123, Maintains Outperform Rating MT
RBC Lifts Price Target on Addus HomeCare to $123 From $121, Maintains Outperform Rating MT
Raymond James Raises Price Target on Addus HomeCare to $125 From $115, Keeps Outperform Rating MT
RBC Lifts Addus HomeCare's Price Target to $121 From $110 After 'Solid' Q3 Results, Keeps Outperform Rating MT
RBC Capital Adjusts Addus HomeCare's Price Target to $110 from $111, Keeps Outperform Rating MT
Oppenheimer Adjusts Addus HomeCare Price Target to $130 From $135, Maintains Outperform Rating MT
Stifel Starts Addus HomeCare at Buy With $101 Price Target MT
Stephens Inc. Adjusts Addus HomeCare's Price Target to $101 From $110, Maintains Overweight Rating MT
RBC Cuts Price Target on Addus HomeCare to $111 From $125, Maintains Outperform Rating MT
BofA Securities Starts Addus HomeCare at Buy With $110 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
118.4 USD
Average target price
122.6 USD
Spread / Average Target
+3.48%
High Price Target
135 USD
Spread / Highest target
+13.97%
Low Price Target
83 USD
Spread / Lowest Target
-29.93%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Addus HomeCare Corporation

TD Cowen
Oppenheimer
Stephens Inc.
RBC Capital Markets
BofA Securities
Barclays
Raymond James
Stifel Nicolaus
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
  1. Stock Market
  2. Equities
  3. ADUS Stock
  4. Consensus Addus HomeCare Corporation